D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$520M |
| 2 |
Accenture
ACN
|
+$474M |
| 3 |
Intel
INTC
|
+$436M |
| 4 |
Adobe
ADBE
|
+$318M |
| 5 |
Northrop Grumman
NOC
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Apple
AAPL
|
+$900M |
| 3 |
Microsoft
MSFT
|
+$733M |
| 4 |
Netflix
NFLX
|
+$637M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Financials | 7.13% |
| 4 | Healthcare | 6.41% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
3801
DELISTED
Amedisys
AMED
| $283K | ﹤0.01% |
3,078
-1,414
| -31% | -$131K |
|
3802
Hagerty
HGTY
$1.18B
| $281K | ﹤0.01% |
27,040
+28
| +0.1% | +$260 |
|
3803
Regal Rexnord
RRX
$13.9B
| $280K | ﹤0.01% |
+2,072
| New | +$322K |
|
3804
BCB Bancorp
BCBP
$178M
| $280K | ﹤0.01% |
+26,335
| New | +$263K |
|
3805
Phreesia
PHR
$653M
| $279K | ﹤0.01% |
+13,160
| New | +$286K |
|
3806
Schrodinger
SDGR
$1.13B
| $278K | ﹤0.01% |
+14,398
| New | +$332K |
|
3807
Invitation Homes
INVH
$17.5B
| $278K | ﹤0.01% |
7,744
+2,061
| +36% | +$71.6K |
|
|
SBDS
3808
DELISTED
Solo Brands Inc
SBDS
| $278K | ﹤0.01% |
3,045
-486
| -14% | -$38.3K |
|
|
RVNC
3809
DELISTED
Revance Therapeutics, Inc.
RVNC
| $278K | ﹤0.01% |
107,980
-190,130
| -64% | -$649K |
|
3810
ONE Gas
OGS
$4.86B
| $277K | ﹤0.01% |
4,345
-571
| -12% | -$35.8K |
|
|
RYZ
3811
Ryerson Holding Corp
RYZ
$1.39B
| $277K | ﹤0.01% |
+14,184
| New | +$365K |
|
3812
iShares Select U.S. REIT ETF
ICF
$2.09B
| $277K | ﹤0.01% |
+4,827
| New | +$268K |
|
3813
Koppers
KOP
$931M
| $276K | ﹤0.01% |
7,459
+2,195
| +42% | +$102K |
|
3814
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $274K | ﹤0.01% |
+3,109
| New | +$275K |
|
|
SMAR
3815
PUT
DELISTED
Smartsheet Inc.
SMAR
| $273K | ﹤0.01% |
+6,200
| New | +$247K |
|
3816
Marcus & Millichap
MMI
$1.17B
| $273K | ﹤0.01% |
+8,656
| New | +$280K |
|
3817
Myers Industries
MYE
$1.25B
| $272K | ﹤0.01% |
+20,338
| New | +$370K |
|
3818
GXO Logistics
GXO
$5.81B
| $272K | ﹤0.01% |
+5,386
| New | +$272K |
|
3819
Health Catalyst
HCAT
$154M
| $271K | ﹤0.01% |
+42,441
| New | +$272K |
|
3820
VTEX
VTEX
$728M
| $270K | ﹤0.01% |
37,178
-328,084
| -90% | -$2.38M |
|
3821
CALL
ACM Research
ACMR
$5.75B
| $270K | ﹤0.01% |
+11,700
| New | +$296K |
|
3822
PUT
Intrepid Potash
IPI
$470M
| $269K | ﹤0.01% |
11,500
| – | – |
|
3823
Stellantis
STLA
$16.8B
| $268K | ﹤0.01% |
13,500
-476,838
| -97% | -$11M |
|
|
AOMR
3824
Angel Oak Mortgage REIT
AOMR
$221M
| $268K | ﹤0.01% |
20,425
-5,190
| -20% | -$60.5K |
|
|
UHGWW
3825
DELISTED
United Homes Group Warrant
UHGWW
| $267K | ﹤0.01% |
439,789
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2024 Portfolio in Review
As of Q2 2024, D.E. Shaw & Co held 4,975 positions worth $107B, down 8.5% from $117B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $20B in Q2 2024, closing 541 positions and reducing 1,567 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $542M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $258M.
- D.E. Shaw & Co's largest Q2 2024 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 2,917,600 shares worth $258M.
- D.E. Shaw & Co added most to Broadcom in Q2 2024, an estimated $520M increase.
- D.E. Shaw & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $1.23B.
- D.E. Shaw & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $542M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $107B portfolio in Q2 2024.
- D.E. Shaw & Co opened 693 new positions and closed 541 in Q2 2024.
- D.E. Shaw & Co's portfolio value fell 8.5% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.